Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

VA Technical Reference Model v 24.4

Oncotopix Technology

General InformationGeneral Information help

Technologies must be operated and maintained in accordance with Federal and Department security and privacy policies and guidelines. More information on the proper use of the TRM can be found on the TRM Proper Use Tab/Section.

Website: Go to site
Description: Oncotopix is software specifically designed for the characterization and quantification of physiological structures and biomarkers in digital whole slide images. Image analysis algorithms, called APPs, can be authored and then loaded and executed, either on individual regions of interest (ROIs), entire whole slide images, or large batches of images. The logical, searchable hierarchical database automatically gets populated with results, identified regions, and cellular structures.

Data is stored in a Microsoft Structured Query Language (SQL) Server database.

Oncotopix was rebranded from BIOtopix in March 2022.
Technology/Standard Usage Requirements: Users must ensure their use of this technology/standard is consistent with VA policies and standards, including, but not limited to, VA Handbooks 6102 and 6500; VA Directives 6004, 6513, and 6517; and National Institute of Standards and Technology (NIST) standards, including Federal Information Processing Standards (FIPS). Users must ensure sensitive data is properly protected in compliance with all VA regulations. Prior to use of this technology, users should check with their supervisor, Information Security Officer (ISO), Facility Chief Information Officer (CIO), or local Office of Information and Technology (OI&T) representative to ensure that all actions are consistent with current VA policies and procedures prior to implementation.
Section 508 Information: This technology qualifies for a legally-defined Exception (Fundamental Alteration) as determined by the VA Section 508 Office and will not need a 508 assessment prior to implementation. For additional information or assistance regarding Section 508, please contact the Section 508 office at
Decision: View Decisions

Decision Source: TRM Mgmt Group
Decision Process: One-VA TRM v22.8
Decision Date: 08/08/2022 at 17:52:03 UTC
Aliases: VISIOmorph PLUS, BIOptix
Introduced By: TRM Request
Vendor Name: VisioPharm
- The information contained on this page is accurate as of the Decision Date (08/08/2022 at 17:52:03 UTC).